GAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore...
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire GAITHERSBURG...
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies...
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance PR Newswire GAITHERSBURG...
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation PR...
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 PR Newswire GAITHERSBURG, Md., Sept. 10, 2024...
LakeShore Biopharma Announces Leadership Transitions PR Newswire GAITHERSBURG, Md., Sept. 4, 2024...
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 PR Newswire GAITHERSBURG, Md., Aug. 15...
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders...
ANNOUNCEMENT APPOINTMENT OF A NEW DIRECTOR London Scottish Bank plc has today appointed Alan Benzie as a non-executive Director of the Company...
Preliminary Announcement of Final Results for the year ended 31 October 2003 Strong final results; good profit growth across all divisions 14...
LONDON SCOTTISH BANK PUBLIC LIMITED COMPANY NOTIFICATION OF BOARD MEETING The Board of London Scottish Bank plc will be announcing its results...
SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company LONDON SCOTTISH BANK PUBLIC LIMITED COMPANY 2. Name of scheme LONDON SCOTTISH...
12 November 2003 London Scottish Bank plc Close period trading update reports continued progress for the second half London Scottish Bank ("LSB...
LONDON SCOTTISH BANK PUBLIC LIMITED COMPANY HOLDING IN COMPANY We were informed today by Scottish Widows Investment Partnership, that they no...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.